An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
Clinical trial NCT03740230 · COMPLETED
Trial details
- NCT number
- NCT03740230
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-26
- Primary completion
- 2023-07-21
- Enrollment
- 3134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.